MannKind (MNKD)
(Delayed Data from NSDQ)
$5.82 USD
-0.07 (-1.19%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $5.82 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth F Momentum C VGM
Brokerage Reports
0 items in cart
MannKind Corporation [MNKD]
Reports for Purchase
Showing records 121 - 140 ( 228 total )
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Initiating Coverage with a Market Outperform and a $12 price target.
Provider: BRINSON PATRICK SECURITIES CORPORATION
Analyst: JAMES C
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Management is laying the foundation for Afrezza?s debut.
Provider: Griffin Securities, Inc.
Analyst: MARKEY K
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
NDA will be submitted in mid-October, as planned.
Provider: Griffin Securities, Inc.
Analyst: MARKEY K
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
We reiterate our BUY recommendation and maintain our price target to $11.00.
Provider: Griffin Securities, Inc.
Analyst: MARKEY K
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Research Coverage Under Reivew
Provider: BRINSON PATRICK SECURITIES CORPORATION